ridaforolimus 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
immunosuppressants, rapamycin derivatives 4778 572924-54-0

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • deforolimus
  • ridaforolimus
  • AP23573
  • MK-8669
  • jenzyl
an mTOR inhibitor for the treatment of cancer
  • Molecular weight: 990.22
  • Formula: C53H84NO14P
  • CLOGP: 7.20
  • LIPINSKI: 3
  • HAC: 15
  • HDO: 2
  • TPSA: 201.50
  • ALOGS: -6.09
  • ROTB: 8

Drug dosage:

None

ADMET properties:

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

None

ridaforolimus